Aβ40 | Aβ42 | ||
---|---|---|---|
pmol/g wet wt. | |||
Soluble Aβ | |||
Veh/SAL | 0.095 ± 0.002 | 0.093 ± 0.008 | |
Thio/SAL | 0.087 ± 0.004 | 0.079 ± 0.002 | |
Thio/NAL | 0.089 ± 0.003 | 0.077 ± 0.002 | |
Insoluble Aβ | |||
Veh/SAL | 0.409 ± 0.018 | 0.321 ± 0.036 | |
Thio/SAL | 0.746 ± 0.035** | 0.466 ± 0.020** | |
Thio/NAL | 0.688 ± 0.061** | 0.455 ± 0.036* | |
Total Aβ | |||
Veh/SAL | 0.504 ± 0.017 | 0.414 ± 0.035 | |
Thio/SAL | 0.832 ± 0.036** | 0.545 ± 0.019** | |
Thio/NAL | 0.802 ± 0.070** | 0.531 ± 0.035** |
↵* p < 0.05; ** p < 0.01 compared with Veh/SAL-treated rats.